Scott Braunstein

Filings by Scott Braunstein span 6 companies, the busiest being Marinus Pharmaceuticals, Inc., Pacira BioSciences, Inc. and RAPT Therapeutics, Inc. Over a trading history stretching from 29 January 2016 to 3 March 2026, the count stands at 23 filings.

The open-market side counts 3 purchases for €225k alongside 5 sales for €207k. Taken together, the purchases exceed the sales by €18k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 11 share grants and 1 option exercise.

Half of the purchases are above €108k and half below. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 5 March 2026: a transaction, in RAPT Therapeutics, Inc. The last insider purchase was made public on 11 February 2025, 620 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.